216 related articles for article (PubMed ID: 31827644)
1. Expression of LGR5, FZD7, TROY, and MIST1 in Perioperatively Treated Gastric Carcinomas and Correlation with Therapy Response.
Freiin Grote A; Halske C; Behrens HM; Krüger S; Wilhelm F; Egberts JH; Röcken C
Dis Markers; 2019; 2019():8154926. PubMed ID: 31827644
[TBL] [Abstract][Full Text] [Related]
2. Prognostic significance of leucine-rich-repeat-containing G-protein-coupled receptor 5, an intestinal stem cell marker, in gastric carcinomas.
Jang BG; Lee BL; Kim WH
Gastric Cancer; 2016 Jul; 19(3):767-77. PubMed ID: 26386561
[TBL] [Abstract][Full Text] [Related]
3. LGR5 and CD133 as prognostic and predictive markers for fluoropyrimidine-based adjuvant chemotherapy in colorectal cancer.
Stanisavljević L; Myklebust MP; Leh S; Dahl O
Acta Oncol; 2016 Dec; 55(12):1425-1433. PubMed ID: 27435662
[TBL] [Abstract][Full Text] [Related]
4. Expression profile of intestinal stem cell and cancer stem cell markers in gastric cancers with submucosal invasion.
Kim HS; Song HJ; Kim HU; Jeong IH; Koh HM; Shin JH; Jang BG
Pathol Res Pract; 2021 Feb; 218():153336. PubMed ID: 33450435
[TBL] [Abstract][Full Text] [Related]
5. The spatial distribution of LGR5+ cells correlates with gastric cancer progression.
Simon E; Petke D; Böger C; Behrens HM; Warneke V; Ebert M; Röcken C
PLoS One; 2012; 7(4):e35486. PubMed ID: 22530031
[TBL] [Abstract][Full Text] [Related]
6. Intestinal stem cell marker LGR5 expression during gastric carcinogenesis.
Zheng ZX; Sun Y; Bu ZD; Zhang LH; Li ZY; Wu AW; Wu XJ; Wang XH; Cheng XJ; Xing XF; Du H; Ji JF
World J Gastroenterol; 2013 Dec; 19(46):8714-21. PubMed ID: 24379591
[TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical Analysis of LGR5 and TROY Expression in Gastric Carcinogenesis Demonstrates an Inverse Trend.
Saberi S; Piryaei A; Mirabzadeh E; Esmaeili M; Karimi T; Momtaz S; Abdirad A; Sodeifi N; Mohagheghi MA; Baharvand H; Mohammadi M
Iran Biomed J; 2019 Mar; 23(2):107-20. PubMed ID: 30501144
[TBL] [Abstract][Full Text] [Related]
8. Frizzled-7 Identifies Platinum-Tolerant Ovarian Cancer Cells Susceptible to Ferroptosis.
Wang Y; Zhao G; Condello S; Huang H; Cardenas H; Tanner EJ; Wei J; Ji Y; Li J; Tan Y; Davuluri RV; Peter ME; Cheng JX; Matei D
Cancer Res; 2021 Jan; 81(2):384-399. PubMed ID: 33172933
[TBL] [Abstract][Full Text] [Related]
9. Clinical Significance of Tumour CD44v and MIST1 Expression in Patients With Non-small-cell Lung Cancer.
Nagashima T; Oshima T; Hiroshima Y; Yokose T; Woo T; Rino Y; Masuda M; Miyagi Y; Ito H; Nakayama H
Anticancer Res; 2020 Nov; 40(11):6407-6416. PubMed ID: 33109579
[TBL] [Abstract][Full Text] [Related]
10. [Expression of stem cell markers CD44 and Lgr5 in colorectal cancer and its relationship with lymph node and liver metastasis].
Wang XF; Zhang XL; Xu LP; Shi GG; Zheng HY; Sun BC
Zhonghua Yi Xue Za Zhi; 2018 Sep; 98(36):2899-2904. PubMed ID: 30293346
[No Abstract] [Full Text] [Related]
11. Aberrant Expression of Markers of Cancer Stem Cells in Gastric Adenocarcinoma and their Relationship to Vasculogenic Mimicry.
Zhou L; Yu L; Feng ZZ; Gong XM; Cheng ZN; Yao N; Wang DN; Wu SW
Asian Pac J Cancer Prev; 2015; 16(10):4177-83. PubMed ID: 26028069
[TBL] [Abstract][Full Text] [Related]
12. Podocalyxin-like protein as a predictive biomarker for benefit of neoadjuvant chemotherapy in resectable gastric and esophageal adenocarcinoma.
Borg D; Larsson AH; Hedner C; Nodin B; Johnsson A; Jirström K
J Transl Med; 2018 Oct; 16(1):290. PubMed ID: 30355278
[TBL] [Abstract][Full Text] [Related]
13. Frizzled7 Promotes Epithelial-to-mesenchymal Transition and Stemness Via Activating Canonical Wnt/β-catenin Pathway in Gastric Cancer.
Li G; Su Q; Liu H; Wang D; Zhang W; Lu Z; Chen Y; Huang X; Li W; Zhang C; He Y; Fu L; Bi J
Int J Biol Sci; 2018; 14(3):280-293. PubMed ID: 29559846
[TBL] [Abstract][Full Text] [Related]
14. Targeting Frizzled-7 Decreases Stemness and Chemotherapeutic Resistance in Gastric Cancer Cells by Suppressing Myc Expression.
Cheng Y; Li L; Pan S; Jiang H; Jin H
Med Sci Monit; 2019 Nov; 25():8637-8644. PubMed ID: 31733054
[TBL] [Abstract][Full Text] [Related]
15. LGR4 and LGR6 are differentially expressed and of putative tumor biological significance in gastric carcinoma.
Steffen JS; Simon E; Warneke V; Balschun K; Ebert M; Röcken C
Virchows Arch; 2012 Oct; 461(4):355-65. PubMed ID: 22855134
[TBL] [Abstract][Full Text] [Related]
16. [GRP78 expression in gastric cancer and its clinical significance].
Yang L; Yang SY; Ji JM; Cao YF; Ji CF; Ji JF; Xu WW; Wang JH
Zhonghua Zhong Liu Za Zhi; 2013 Nov; 35(11):837-42. PubMed ID: 24447482
[TBL] [Abstract][Full Text] [Related]
17. Increased expression of Lgr5 is associated with chemotherapy resistance in human gastric cancer.
Xi HQ; Cui JX; Shen WS; Wu XS; Bian SB; Li JY; Song Z; Wei B; Chen L
Oncol Rep; 2014 Jul; 32(1):181-8. PubMed ID: 24859092
[TBL] [Abstract][Full Text] [Related]
18. Lgr5 expression as stem cell marker in human gastric gland and its relatedness with other putative cancer stem cell markers.
Wu C; Xie Y; Gao F; Wang Y; Guo Y; Tian H; Li Y; Fan W
Gene; 2013 Aug; 525(1):18-25. PubMed ID: 23664892
[TBL] [Abstract][Full Text] [Related]
19. [Ways to personalized medicine for gastric cancer].
Röcken C
Pathologe; 2013 Sep; 34(5):403-12. PubMed ID: 23907566
[TBL] [Abstract][Full Text] [Related]
20. LGR5 Is a Gastric Cancer Stem Cell Marker Associated with Stemness and the EMT Signature Genes NANOG, NANOGP8, PRRX1, TWIST1, and BMI1.
Wang B; Chen Q; Cao Y; Ma X; Yin C; Jia Y; Zang A; Fan W
PLoS One; 2016; 11(12):e0168904. PubMed ID: 28033430
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
